ADAR1 Capital Management »

Editas Medicine shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $29M 8.9M 3.24

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Editas Medicine

BlackRock
ADAR1 Capital Management
RA Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
State Street Corporation
Marshall Wace
Nuveen
Opaleye Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Two Sigma Investments

View all funds holding Editas Medicine